Russell Frank Company’s Esperion Therapeutics ESPR Stock Holding History

Russell Frank Company’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$300K	Buy	17,722 +81	+0.5%	+$1.3K	﹤0.01%	2604
2015 Q4	$402K	Sell	17,641 -53,263	-75%	-$1.34M	﹤0.01%	2544
2015 Q3	$1.67M	Sell	70,904 -14,224	-17%	-$893K	﹤0.01%	1954
2015 Q2	$6.96M	Buy	85,128 +60,617	+247%	+$5.93M	0.01%	1218
2015 Q1	$2.27M	Sell	24,511 -42,746	-64%	-$2.76M	﹤0.01%	1702
2014 Q4	$2.71M	Buy	+67,257	New	+$2.06M	﹤0.01%	1610

Other funds holding ESPR

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

VOYA Investment Management

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return